{"id":115137,"name":"SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.)","slug":"sunovion-pharmaceuticals-inc-formerly-known-as-sepracor-inc","state":null,"country":"* Undetermined","description":"","totalSpending":1450000,"filings":21,"yearlySpending":[{"year":2018,"income":270000},{"year":2019,"income":280000},{"year":2020,"income":270000},{"year":2021,"income":280000},{"year":2022,"income":280000},{"year":2023,"income":70000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"}],"firms":["COVINGTON & BURLING LLP"],"lobbyists":["JOAN KUTCHER","MUFTIAH MCCARTIN","GARY HEIMBERG","GABRIEL NEVILLE","LAYTH ELHASSANI"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Medicare reimbursement of prescription drugs; mental health legislation.","Medicare reimbursement of prescription drugs; mental health legislation.","Medicare reimbursement of prescription drugs.","Drug innovation issues.","Medicare reimbursement of prescription drugs."]}